ACH
ALXN

ArrowMark Colorado Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

ArrowMark Colorado Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-19,055
Closed -$2.98M – 331
2014
Q2 		$2.98M Hold
19,055
– – 0.08% 173
2014
Q1 		$2.9M Sell
19,055
-175
-0.9% -$27.8K 0.09% 167
2013
Q4 		$2.56M Buy
19,230
+730
+4% +$87.6K 0.08% 167
2013
Q3 		$2.15M Hold
18,500
– – 0.07% 180
2013
Q2 		$1.71M Buy
+18,500
New +$1.78M 0.46% 54

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return